Background Evidence indicates that the inverse relationships between phosphate levels
and mortality maybe modified by age. Furthermore, malnutrition and inflammation could …

Hyperphosphatemia has consistently been shown to be associated with dismal outcome in a
wide variety of populations, particularly in chronic kidney disease (CKD). Compelling …

Background Hyperphosphataemia is an independent risk factor for accelerated
cardiovascular disease in chronic kidney disease (CKD), although the mechanism for this is …

Left ventricular hypertrophy (LVH) is the most frequent cardiac abnormality in patients with
end-stage renal disease (ESRD). Recent studies have shown that arterial stiffness is …

Hyperphosphatemia is associated with an increased risk of cardiovascular morbidity and
mortality. However, in our large cross-sectional study, high serum phosphorus levels were …

Introduction Elevated phosphate (P) in urine may reflect a high intake of inorganic P salts
from food additives. Elevated P in plasma is linked to vascular dysfunction and calcification …

Background Increased arterial stiffness and vascular calcification have been recognized as
important predictors of cardiovascular mortality in patients with chronic kidney disease …

Hyperphosphataemia is a frequent and important cardiovascular risk factor in patients with
chronic kidney disease (CKD). High phosphate levels may influence vascular calcifications …

PURPOSE: Whether higher serum phosphorus levels increase risk for kidney disease onset
and progression to end-stage renal disease in those with normal renal function is largely …

Serum phosphorus levels stay relatively constant through the influence of multiple factors—
such as parathyroid hormone, fibroblast growth factor 23, and vitamin D—on the kidney …